Document Type
Article
Publication Date
7-1-2019
Publication Title
Ann Transl Med
Abstract
Background: The relationship between survivin and extranodal, nasal-type natural killer/T cell lymphoma (ENKTCL) was unclearly established yet. We here studied the potential prognostic roles of survivin and its implication as a target in ENKTCL therapy.
Methods: ENKTCL patients' peripheral blood were collected and tested by ELISA. ENKTCL cell lines were cultured with or without survivin inhibitor and tested by MTT and Flow cytometry. According to the gene expression profiles from the ArrayExpress Archive under E-TABM-702, survivin co-regulated cluster was established by Coupled Two-way Clustering Algorithm.
Results: Seventeen point six percent of total 17 ENKTCL patients were serum survivin-positive. These patients had poorer outcome than that of negative cases (P
Conclusions: We concluded that survivin was a potential prognostic marker and a critical regulatory molecule in the pathological process of ENKTCL. It would be a promising target in drugs discovery for ENKTCL therapy.
Clinical Institute
Cancer
Department
Institute for Systems Biology
Department
Oncology
Recommended Citation
Zhang, Li; Wei, Yi; Yan, Xiaowei; Li, Na; Song, Haolan; Yang, Li; Wu, Yang; Xi, Yu-Feng; Weng, Hua-Wei; Li, Jian-Hua; Lin, Edward H; and Zou, Li-Qun, "Survivin is a prognostic marker and therapeutic target for extranodal, nasal-type natural killer/T cell lymphoma." (2019). Articles, Abstracts, and Reports. 2177.
https://digitalcommons.providence.org/publications/2177
